Letters

Consensus statement on management of hypothyroidism and hyperthyroidism

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7070.1487a (Published 07 December 1996) Cite this as: BMJ 1996;313:1487

Long term treatment is not safe in elderly patients with toxic nodular hyperthyroidism

  1. I K Takacs,
  2. I Szabolcs,
  3. M Goth,
  4. O Dohan,
  5. L Kovacs,
  6. G Szilagyi,
  7. J Foldes
  1. (research scientist), (senior lecturer), (senior lecturer), (lecturer), (lecturer), (professor of medicine), division of endocrinology, first department of medicine, Haynal University of Health Sciences, Budapest, PO Box 112, H-1389 Hungary; (professor of medicine), first department of medicine, Semmelweis Medical School, Budapest, H-1083 Hungary

    EDITOR,—According to the consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism, “long term treatment with 5–10 mg carbimazole seems to be safe and is an option for patients with relapsed Graves' disease or toxic …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe